Recent contributions of in vitro models to our understanding of hepatitis C virus life cycle

FEBS Journal

Volumn 274, Issue 18, 2007, Pages 4705-4718

  Régeard, Morgane ^a   Lepère, Charlotte ^a   Trotard, Maud ^a   Gripon, Philippe ^a   Le Seyec, Jacques ^a  

^a PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

Author keywords

Assembly; Hepatitis C virus; In vitro models; Infection; Replication

Indexed keywords

CELL CLONING; CELL CULTURE; CELL LINE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IN VITRO STUDY; LIFE CYCLE; NONHUMAN; PRIORITY JOURNAL; REPLICON; REVIEW; VIRUS GENOME; VIRUS REPLICATION;

ANIMALS; HEPACIVIRUS; HEPATITIS C; HUMANS; MODELS, BIOLOGICAL; REPLICON; VIRION; VIRUS REPLICATION;

HEPATITIS C VIRUS; PAN;

EID: 34548382210     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2007.06017.x     Document Type: Review

References (104)

1. WHO (1997) Hepatitis C global prevalence. Wkly Epidemiol Rec 72, 341 344.
2. Lohmann V, Korner F, Koch J, Herian U, Theilmann L Bartenschlager R (1999) Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285, 110 113.
3. Blight KJ, Kolykhalov AA Rice CM (2000) Efficient initiation of HCV RNA replication in cell culture. Science 290, 1972 1974.
4. Guo JT, Bichko VV Seeger C (2001) Effect of alpha interferon on the hepatitis C virus replicon. J Virol 75, 8516 8523.
5. Krieger N, Lohmann V Bartenschlager R (2001) Enhancement of hepatitis C virus RNA replication by cell culture-adaptive mutations. J Virol 75, 4614 4624.
6. Lohmann V, Korner F, Dobierzewska A Bartenschlager R (2001) Mutations in hepatitis C virus RNAs conferring cell culture adaptation. J Virol 75, 1437 1449.
7. Bukh J, Pietschmann T, Lohmann V, Krieger N, Faulk K, Engle RE, Govindarajan S, Shapiro M, St Claire M Bartenschlager R (2002) Mutations that permit efficient replication of hepatitis C virus RNA in Huh-7 cells prevent productive replication in chimpanzees. Proc Natl Acad Sci USA 99, 14416 14421.
8. Blight KJ, McKeating JA Rice CM (2002) Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J Virol 76, 13001 13014.
9. Friebe P, Boudet J, Simorre JP Bartenschlager R (2005) Kissing-loop interaction in the 3′ end of the hepatitis C virus genome essential for RNA replication. J Virol 79, 380 392.
10. Zhong J, Gastaminza P, Cheng G, Kapadia S, Kato T, Burton DR, Wieland SF, Uprichard SL, Wakita T Chisari FV (2005) Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci USA 102, 9294 9299.
11. Lanford RE, Guerra B, Lee H, Averett DR, Pfeiffer B, Chavez D, Notvall L Bigger C (2003) Antiviral effect and virus-host interactions in response to alpha interferon, gamma interferon, poly(I)-poly(C), tumor necrosis factor alpha, and ribavirin in hepatitis C virus subgenomic replicons. J Virol 77, 1092 1104.
12. Sumpter R Jr., Loo YM, Foy E, Li K, Yoneyama M, Fujita T, Lemon SM Gale M Jr. (2005) Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I. J Virol 79, 2689 2699.
13. Moradpour D, Evans MJ, Gosert R, Yuan Z, Blum HE, Goff SP, Lindenbach BD Rice CM (2004) Insertion of green fluorescent protein into nonstructural protein 5A allows direct visualization of functional hepatitis C virus replication complexes. J Virol 78, 7400 7409.
14. Murray EM, Grobler JA, Markel EJ, Pagnoni MF, Paonessa G, Simon AJ Flores OA (2003) Persistent replication of hepatitis C virus replicons expressing the beta-lactamase reporter in subpopulations of highly permissive Huh7 cells. J Virol 77, 2928 2935.
15. Yi M, Bodola F Lemon SM (2002) Subgenomic hepatitis C virus replicons inducing expression of a secreted enzymatic reporter protein. Virology 304, 197 210.
16. Blight KJ, McKeating JA, Marcotrigiano J Rice CM (2003) Efficient replication of hepatitis C virus genotype 1a RNAs in cell culture. J Virol 77, 3181 3190.
17. Kato T, Date T, Miyamoto M, Furusaka A, Tokushige K, Mizokami M Wakita T (2003) Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon. Gastroenterology 125, 1808 1817.
18. Ikeda M, Yi M, Li K Lemon SM (2002) Selectable subgenomic and genome-length dicistronic RNAs derived from an infectious molecular clone of the HCV-N strain of hepatitis C virus replicate efficiently in cultured Huh7 cells. J Virol 76, 2997 3006.
19. Pietschmann T, Lohmann V, Kaul A, Krieger N, Rinck G, Rutter G, Strand D Bartenschlager R (2002) Persistent and transient replication of full-length hepatitis C virus genomes in cell culture. J Virol 76, 4008 4021.
20. Wakita T, Pietschmann T, Kato T, Date T, Miyamoto M, Zhao Z, Murthy K, Habermann A, Krausslich HG, Mizokami M et al. (2005) Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 11, 791 796.
21. Bartenschlager R, Frese M Pietschmann T (2004) Novel insights into hepatitis C virus replication and persistence. Adv Virus Res 63, 71 180.
22. Lindenbach BD Rice CM (2005) Unravelling hepatitis C virus replication from genome to function. Nature 436, 933 938.
23. De Francesco R Migliaccio G (2005) Challenges and successes in developing new therapies for hepatitis C. Nature 436, 953 960.
24. Andre P, Komurian-Pradel F, Deforges S, Perret M, Berland JL, Sodoyer M, Pol S, Brechot C, Paranhos-Baccala G Lotteau V (2002) Characterization of low- and very-low-density hepatitis C virus RNA-containing particles. J Virol 76, 6919 6928.
25. Nielsen SU, Bassendine MF, Burt AD, Martin C, Pumeechockchai W Toms GL (2006) Association between hepatitis C virus and very-low-density lipoprotein (VLDL)/LDL analyzed in iodixanol density gradients. J Virol 80, 2418 2428.
26. Prince AM, Huima-Byron T, Parker TS Levine DM (1996) Visualization of hepatitis C virions and putative defective interfering particles isolated from low-density lipoproteins. J Viral Hepat 3, 11 17.
27. Thomssen R, Bonk S, Propfe C, Heermann KH, Kochel HG Uy A (1992) Association of hepatitis C virus in human sera with beta-lipoprotein. Med Microbiol Immunol 181, 293 300.
28. Thomssen R, Bonk S Thiele A (1993) Density heterogeneities of hepatitis C virus in human sera due to the binding of beta-lipoproteins and immunoglobulins. Med Microbiol Immunol 182, 329 334.
29. Bradley D, McCaustland K, Krawczynski K, Spelbring J, Humphrey C Cook EH (1991) Hepatitis C virus: buoyant density of the factor VIII-derived isolate in sucrose. J Med Virol 34, 206 208.
30. Hijikata M, Shimizu YK, Kato H, Iwamoto A, Shih JW, Alter HJ, Purcell RH Yoshikura H (1993) Equilibrium centrifugation studies of hepatitis C virus: evidence for circulating immune complexes. J Virol 67, 1953 1958.
31. Kanto T, Hayashi N, Takehara T, Hagiwara H, Mita E, Naito M, Kasahara A, Fusamoto H Kamada T (1995) Density analysis of hepatitis C virus particle population in the circulation of infected hosts: implications for virus neutralization or persistence. J Hepatol 22, 440 448.
32. Maillard P, Krawczynski K, Nitkiewicz J, Bronnert C, Sidorkiewicz M, Gounon P, Dubuisson J, Faure G, Crainic R Budkowska A (2001) Nonenveloped nucleocapsids of hepatitis C virus in the serum of infected patients. J Virol 75, 8240 8250.
33. Castet V, Fournier C, Soulier A, Brillet R, Coste J, Larrey D, Dhumeaux D, Maurel P Pawlotsky JM (2002) Alpha interferon inhibits hepatitis C virus replication in primary human hepatocytes infected in vitro. J Virol 76, 8189 8199.
34. Lazaro CA, Chang M, Tang W, Campbell J, Sullivan DG, Gretch DR, Corey L, Coombs RW Fausto N (2007) Hepatitis C virus replication in transfected and serum-infected cultured human fetal hepatocytes. Am J Pathol 170, 478 489.
35. Fournier C, Sureau C, Coste J, Ducos J, Pageaux G, Larrey D, Domergue J Maurel P (1998) In vitro infection of adult normal human hepatocytes in primary culture by hepatitis C virus. J Gen Virol 79, 2367 2374.
36. Rumin S, Berthillon P, Tanaka E, Kiyosawa K, Trabaud MA, Bizollon T, Gouillat C, Gripon P, Guguen-Guillouzo C, Inchauspe G et al. (1999) Dynamic analysis of hepatitis C virus replication and quasispecies selection in long-term cultures of adult human hepatocytes infected in vitro. J Gen Virol 80, 3007 3018.
37. Lanford RE, Sureau C, Jacob JR, White R Fuerst TR (1994) Demonstration of in vitro infection of chimpanzee hepatocytes with hepatitis C virus using strand-specific RT/PCR. Virology 202, 606 614.
38. Zhao X, Tang ZY, Klumpp B, Wolff-Vorbeck G, Barth H, Levy S, von Weizsacker F, Blum HE Baumert TF (2002) Primary hepatocytes of Tupaia belangeri as a potential model for hepatitis C virus infection. J Clin Invest 109, 221 232.
39. Gripon P, Diot C, Theze N, Fourel I, Loreal O, Brechot C Guguen-Guillouzo C (1988) Hepatitis B virus infection of adult human hepatocytes cultured in the presence of dimethyl sulfoxide. J Virol 62, 4136 4143.
40. Rumin S, Gripon P, Le Seyec J, Corral-Debrinski M Guguen-Guillouzo C (1996) Long-term productive episomal hepatitis C virus replication in primary cultures of adult human hepatocytes infected in vitro. J Viral Hepat 3, 227 238.
41. Chong TW, Smith RL, Hughes MG, Camden J, Rudy CK, Evans HL, Sawyer RG Pruett TL (2006) Primary human hepatocytes in spheroid formation to study hepatitis C infection. J Surg Res 130, 52 57.
42. Molina S, Castet V, Fournier-Wirth C, Pichard-Garcia L, Avner R, Harats D, Roitelman J, Barbaras R, Graber P, Ghersa P et al. (2007) The low-density lipoprotein receptor plays a role in the infection of primary human hepatocytes by hepatitis C virus. J Hepatol 46, 411 419.
43. Bartenschlager R Lohmann V (2001) Novel cell culture systems for the hepatitis C virus. Antiviral Res 52, 1 17.
44. Aly HH, Watashi K, Hijikata M, Kaneko H, Takada Y, Egawa H, Uemoto S Shimotohno K (2007) Serum-derived hepatitis C virus infectivity in interferon regulatory factor-7-suppressed human primary hepatocytes. J Hepatol 46, 26 36.
45. Lerat H, Berby F, Trabaud MA, Vidalin O, Major M, Trepo C Inchauspe G (1996) Specific detection of hepatitis C virus minus strand RNA in hematopoietic cells. J Clin Invest 97, 845 851.
46. Cribier B, Schmitt C, Bingen A, Kirn A Keller F (1995) In vitro infection of peripheral blood mononuclear cells by hepatitis C virus. J Gen Virol 76, 2485 2491.
47. Sung VM, Shimodaira S, Doughty AL, Picchio GR, Can H, Yen TS, Lindsay KL, Levine AM Lai MM (2003) Establishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: the apoptotic effects of virus infection. J Virol 77, 2134 2146.
48. Baumert TF, Ito S, Wong DT Liang TJ (1998) Hepatitis C virus structural proteins assemble into virus-like particles in insect cells. J Virol 72, 3827 3836.
49. Baumert TF, Wellnitz S, Aono S, Satoi J, Herion D, Tilman Gerlach J, Pape GR, Lau JY, Hoofnagle JH et al. (2000) Antibodies against hepatitis C virus-like particles and viral clearance in acute and chronic hepatitis C. Hepatology 32, 610 617.
50. Triyatni M, Vergalla J, Davis AR, Hadlock KG, Foung SK Liang TJ (2002) Structural features of envelope proteins on hepatitis C virus-like particles as determined by anti-envelope monoclonal antibodies and CD81 binding. Virology 298, 124 132.
51. Barth H, Schafer C, Adah MI, Zhang F, Linhardt RJ, Toyoda H, Kinoshita-Toyoda A, Toida T, Van Kuppevelt TH, Depla E et al. (2003) Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate. J Biol Chem 278, 41003 41012.
52. Triyatni M, Saunier B, Maruvada P, Davis AR, Ulianich L, Heller T, Patel A, Kohn LD Liang TJ (2002) Interaction of hepatitis C virus-like particles and cells: a model system for studying viral binding and entry. J Virol 76, 9335 9344.
53. Barth H, Schnober EK, Zhang F, Linhardt RJ, Depla E, Boson B, Cosset FL, Patel AH, Blum HE Baumert TF (2006) Viral and cellular determinants of the hepatitis C virus envelope-heparan sulfate interaction. J Virol 80, 10579 10590.
54. Fang X, Zeisel MB, Wilpert J, Gissler B, Thimme R, Kreutz C, Maiwald T, Timmer J, Kern WV, Donauer J et al. (2006) Host cell responses induced by hepatitis C virus binding. Hepatology 43, 1326 1336.
55. Elmowalid GA, Qiao M, Jeong SH, Borg BB, Baumert TF, Sapp RK, Hu Z, Murthy K Liang TJ (2007) Immunization with hepatitis C virus-like particles results in control of hepatitis C virus infection in chimpanzees. Proc Natl Acad Sci USA 104, 8427 8432.
56. Jeong SH, Qiao M, Nascimbeni M, Hu Z, Rehermann B, Murthy K Liang TJ (2004) Immunization with hepatitis C virus-like particles induces humoral and cellular immune responses in nonhuman primates. J Virol 78, 6995 7003.
57. Murata K, Lechmann M, Qiao M, Gunji T, Alter HJ Liang TJ (2003) Immunization with hepatitis C virus-like particles protects mice from recombinant hepatitis C virus-vaccinia infection. Proc Natl Acad Sci USA 100, 6753 6758.
58. Blanchard E, Brand D, Trassard S, Goudeau A Roingeard P (2002) Hepatitis C virus-like particle morphogenesis. J Virol 76, 4073 4079.
59. Ait-Goughoulte M, Hourioux C, Patient R, Trassard S, Brand D Roingeard P (2006) Core protein cleavage by signal peptide peptidase is required for hepatitis C virus-like particle assembly. J Gen Virol 87, 855 860.
60. Blanchard E, Hourioux C, Brand D, Ait-Goughoulte M, Moreau A, Trassard S, Sizaret PY, Dubois F Roingeard P (2003) Hepatitis C virus-like particle budding: role of the core protein and importance of its Asp111. J Virol 77, 10131 10138.
61. Lagging LM, Meyer K, Owens RJ Ray R (1998) Functional role of hepatitis C virus chimeric glycoproteins in the infectivity of pseudotyped virus. J Virol 72, 3539 3546.
62. Buonocore L, Blight KJ, Rice CM Rose JK (2002) Characterization of vesicular stomatitis virus recombinants that express and incorporate high levels of hepatitis C virus glycoproteins. J Virol 76, 6865 6872.
63. Matsuura Y, Tani H, Suzuki K, Kimura-Someya T, Suzuki R, Aizaki H, Ishii K, Moriishi K, Robison CS, Whitt MA et al. (2001) Characterization of pseudotype VSV possessing HCV envelope proteins. Virology 286, 263 275.
64. Sandrin V, Boulanger P, Penin F, Granier C, Cosset FL Bartosch B (2005) Assembly of functional hepatitis C virus glycoproteins on infectious pseudoparticles occurs intracellularly and requires concomitant incorporation of E1 and E2 glycoproteins. J Gen Virol 86, 3189 3199.
65. Deleersnyder V, Pillez A, Wychowski C, Blight K, Xu J, Hahn YS, Rice CM Dubuisson J (1997) Formation of native hepatitis C virus glycoprotein complexes. J Virol 71, 697 704.
66. Duvet S, Cocquerel L, Pillez A, Cacan R, Verbert A, Moradpour D, Wychowski C Dubuisson J (1998) Hepatitis C virus glycoprotein complex localization in the endoplasmic reticulum involves a determinant for retention and not retrieval. J Biol Chem 273, 32088 32095.
67. Bartosch B, Dubuisson J Cosset FL (2003) Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes. J Exp Med 197, 633 642.
68. Op De Beeck A, Voisset C, Bartosch B, Ciczora Y, Cocquerel L, Keck Z, Foung S, Cosset FL Dubuisson J (2004) Characterization of functional hepatitis C virus envelope glycoproteins. J Virol 78, 2994 3002.
69. Hsu M, Zhang J, Flint M, Logvinoff C, Cheng-Mayer C, Rice CM McKeating JA (2003) Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles. Proc Natl Acad Sci USA 100, 7271 7276.
70. Meunier JC, Engle RE, Faulk K, Zhao M, Bartosch B, Alter H, Emerson SU, Cosset FL, Purcell RH Bukh J (2005) Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1. Proc Natl Acad Sci USA 102, 4560 4565.
71. Bartosch B, Vitelli A, Granier C, Goujon C, Dubuisson J, Pascale S, Scarselli E, Cortese R, Nicosia A Cosset FL (2003) Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor. J Biol Chem 278, 41624 41630.
72. Bartosch B, Verney G, Dreux M, Donot P, Morice Y, Penin F, Pawlotsky JM, Lavillette D Cosset FL (2005) An interplay between hypervariable region 1 of the hepatitis C virus E2 glycoprotein, the scavenger receptor BI, and high-density lipoprotein promotes both enhancement of infection and protection against neutralizing antibodies. J Virol 79, 8217 8229.
73. Voisset C, Callens N, Blanchard E, Op De Beeck A, Dubuisson J Vu-Dac N (2005) High density lipoproteins facilitate hepatitis C virus entry through the scavenger receptor class B type I. J Biol Chem 280, 7793 7799.
74. Zhang J, Randall G, Higginbottom A, Monk P, Rice CM McKeating JA (2004) CD81 is required for hepatitis C virus glycoprotein-mediated viral infection. J Virol 78, 1448 1455.
75. Voisset C, Op de Beeck A, Horellou P, Dreux M, Gustot T, Duverlie G, Cosset FL, Vu-Dac N Dubuisson J (2006) High-density lipoproteins reduce the neutralizing effect of hepatitis C virus (HCV)-infected patient antibodies by promoting HCV entry. J Gen Virol 87, 2577 2581.
76. Blanchard E, Belouzard S, Goueslain L, Wakita T, Dubuisson J, Wychowski C Rouille Y (2006) Hepatitis C virus entry depends on clathrin-mediated endocytosis. J Virol 80, 6964 6972.
77. Meertens L, Bertaux C Dragic T (2006) Hepatitis C virus entry requires a critical postinternalization step and delivery to early endosomes via clathrin-coated vesicles. J Virol 80, 11571 11578.
78. Drummer HE, Boo I Poumbourios P (2007) Mutagenesis of a conserved fusion peptide-like motif and membrane-proximal heptad-repeat region of hepatitis C virus glycoprotein E1. J Gen Virol 88, 1144 1148.
79. Lavillette D, Pecheur EI, Donot P, Fresquet J, Molle J, Corbau R, Dreux M, Penin F Cosset FL (2007) Characterization of fusion determinants points to the involvement of three discrete regions of both E1 and E2 glycoproteins in the membrane fusion process of hepatitis C virus. J Virol doi: 10.1128/JVI.02642- 06.
80. Chang KS, Cai Z, Zhang C, Sen GC, Williams BR Luo G (2006) Replication of hepatitis C virus (HCV) RNA in mouse embryonic fibroblasts: protein kinase R (PKR)-dependent and PKR-independent mechanisms for controlling HCV RNA replication and mediating interferon activities. J Virol 80, 7364 7374.
81. Date T, Kato T, Miyamoto M, Zhao Z, Yasui K, Mizokami M Wakita T (2004) Genotype 2a hepatitis C virus subgenomic replicon can replicate in HepG2 and IMY-N9 cells. J Biol Chem 279, 22371 22376.
82. Kato T, Date T, Miyamoto M, Zhao Z, Mizokami M Wakita T (2005) Nonhepatic cell lines HeLa and 293 support efficient replication of the hepatitis C virus genotype 2a subgenomic replicon. J Virol 79, 592 596.
83. Lindenbach BD, Evans MJ, Syder AJ, Wolk B, Tellinghuisen TL, Liu CC, Maruyama T, Hynes RO, Burton DR, McKeating JA et al. (2005) Complete replication of hepatitis C virus in cell culture. Science 309, 623 626.
84. Gastaminza P, Kapadia SB Chisari FV (2006) Differential biophysical properties of infectious intracellular and secreted hepatitis C virus particles. J Virol 80, 11074 11081.
85. Lindenbach BD, Meuleman P, Ploss A, Vanwolleghem T, Syder AJ, McKeating JA, Lanford RE, Feinstone SM, Major ME, Leroux-Roels G et al. (2006) Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro. Proc Natl Acad Sci USA 103, 3805 3809.
86. Kato T, Matsumura T, Heller T, Saito S, Sapp RK, Murthy K, Wakita T Liang TJ (2007) Production of infectious hepatitis C virus of various genotypes in cell cultures. J Virol 81, 4405 4411.
87. Sakai A, Takikawa S, Thimme R, Meunier JC, Spangenberg HC, Govindarajan S, Farci P, Emerson SU, Chisari FV, Purcell RH et al. (2007) In vivo study of the HC-TN strain of hepatitis C virus recovered from a patient with fulminant hepatitis: RNA transcripts of a molecular clone (pHC-TN) are infectious in chimpanzees but not in Huh7.5 cells. J Virol 81, 7208 7219.
88. Yi M, Villanueva RA, Thomas DL, Wakita T Lemon SM (2006) Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells. Proc Natl Acad Sci USA 103, 2310 2315.
89. Pietschmann T, Kaul A, Koutsoudakis G, Shavinskaya A, Kallis S, Steinmann E, Abid K, Negro F, Dreux M, Cosset FL Bartenschlager R (2006) Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras. Proc Natl Acad Sci USA 103, 7408 7413.
90. Yi M, Ma Y, Yates J Lemon SM (2007) Compensatory mutations in E1, 7, NS2, and NS3 enhance yields of cell culture-infectious intergenotypic chimeric hepatitis C virus. J Virol 81, 629 638.
91. Koutsoudakis G, Herrmann E, Kallis S, Bartenschlager R Pietschmann T (2007) The level of CD81 cell surface expression is a key determinant for productive entry of hepatitis C virus into host cells. J Virol 81, 588 598.
92. Akazawa D, Date T, Morikawa K, Murayama A, Miyamoto M, Kaga M, Barth H, Baumert TF, Dubuisson J Wakita T (2007) CD81 expression is important for the permissiveness of huh7 cell clones for heterogeneous hepatitis C virus infection. J Virol 81, 5036 5045.
93. Catanese MT, Graziani R, von Hahn T, Moreau M, Huby T, Paonessa G, Santini C, Luzzago A, Rice CM, Cortese R et al. A (2007) High-avidity monoclonal antibodies against the human scavenger class B type I receptor efficiently block hepatitis C virus infection in the presence of high-density lipoprotein. J Virol 81, 8063 8071.
94. von Hahn T, Lindenbach BD, Boullier A, Quehenberger O, Paulson M, Rice CM McKeating JA (2006) Oxidized low-density lipoprotein inhibits hepatitis C virus cell entry in human hepatoma cells. Hepatology 43, 932 942.
95. Evans MJ, von Hahn T, Tscherne DM, Syder AJ, Panis M, Wolk B, Hatziioannou T, McKeating JA, Bieniasz PD Rice CM (2007) Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 446, 801 805.
96. Koutsoudakis G, Kaul A, Steinmann E, Kallis S, Lohmann V, Pietschmann T Bartenschlager R (2006) Characterization of the early sttif of hepatitis C virus infection by using luciferase reporter viruses. J Virol 80, 5308 5320.
97. Tscherne DM, Jones CT, Evans MJ, Lindenbach BD, McKeating JA Rice CM (2006) Time- and temperature-dependent activation of hepatitis C virus for low-pH-triggered entry. J Virol 80, 1734 1741.
98. Jones CT, Murray CL, Eastman DK, Tassello J Rice CM (2007) Hepatitis C virus p7 and NS2 proteins are essential for infectious virus production. J Virol 101128/JVI00690-07.
99. Huang H, Sun F, Owen DM, Li W, Chen Y, Gale M Jr. Ye J (2007) Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins. Proc Natl Acad Sci USA 104, 5848 5853.
100. Rouille Y, Helle F, Delgrange D, Roingeard P, Voisset C, Blanchard E, Belouzard S, McKeating J, Patel AH, Maertens G et al. (2006) Subcellular localization of hepatitis C virus structural proteins in a cell culture system that efficiently replicates the virus. J Virol 80, 2832 2841.
101. Zhong J, Gastaminza P, Chung J, Stamataki Z, Isogawa M, Cheng G, McKeating JA Chisari FV (2006) Persistent hepatitis C virus infection in vitro: coevolution of virus and host. J Virol 80, 11082 11093.
102. Schaller T, Appel N, Koutsoudakis G, Kallis S, Lohmann V, Pietschmann T Bartenschlager R (2007) Analysis of hepatitis C virus superinfection exclusion by using novel fluorochrome gene-tagged viral genomes. J Virol 81, 4591 4603.
103. Tscherne DM, Evans MJ, von Hahn T, Jones CT, Stamataki Z, McKeating JA, Lindenbach BD Rice CM (2007) Superinfection exclusion in cells infected with hepatitis C virus. J Virol 81, 3693 3703.
104. Binder M, Quinkert D, Bochkarova O, Klein R, Kezmic N, Bartenschlager R Lohmann V (2007) Identification of determinants involved in initiation of hepatitis C virus RNA synthesis by using intergenotypic replicase chimeras. J Virol 81, 5270 5283.